Table 2.

Survey results summary.

	Significant worsening	Worsening	No change	Improvement	Significant Improvement
	1	2	3	4	5
Was there a change in healthcare provision due to COVID-19 pandemic?	7 (2.9%)	36 (14.8%)	169 (69.3%)	31 (12.7%)	1 (0.4%)
Was there a change in your gastroenterologist availability due to COVID-19 pandemic?	2 (0.8%)	21 (8.6%)	181 (74.2%)	36 (14.8%)	4 (1.6%)
	To a very significant extent	To a significant extent	To a medium extent	To a minor extent	Not at all
	1	2	3	4	5
Are you afraid of a severe COVID-19 infection due to your illness or your IBD medications?	57 (23.4%)	53 (21.7%)	46 (18.9%)	42 (17.2%)	46 (18.9%)
Do you feel a need for emotional support due to COVID-19 pandemic?	8 (3.3%)	20 (8.2%)	33 (13.5%)	34 (13.9%)	149 (61.1%)
Do you obey the MOH restrictions and guidance?	173 (70.9%)	55 (22.5%)	13 (5.3%)	2 (0.8%)	1 (0.4%)
	Very Afraid	Afraid	Neutral	Not afraid	Not at all
	1	2	3	4	5
Are you afraid to attend the gastroenterology Institute during the COVID-19 Pandemic?	29 (11.9%)	87 (35.7%)	30 (12.3%)	72 (29.5%)	26 (10.7%)
Are you afraid to attend the ER in case of IBD exacerbation during the COVID-19 pandemic?	84 (34.4%)	94 (38.5%)	13 (5.3%)	43 (17.6%)	10 (4.1%)
	Not at all	Not enough	Sufficiently	Updated	Very updated
	1	2	3	4	5
Do you feel informed about the effect of COVID-19 on patients with IBD?	87 (35.7%)	47 (19.3%)	41 (16.8%)	49 (20.1%)	20 (8.2%)
	Yes	No
Have you taken protective measures, in addition to the measures recommended by the MOH?	120 (49.2%)	124 (50.8%)
Did you stop or change your treatment because of the COVID-19 pandemic?	7 (2.9%)	237 (97.1%)
Did you consider stopping or changing your treatment due to the COVID-19 pandemic?	22 (9 %)	222 (91%)
Have you refrained from going to the pharmacy in order to purchase your medications during the COVID-19 pandemic?	28 (11.5%)	215 (88.5%)

IBD inflammatory bowel disease, MOH Ministry of Health, ER emergency room, COVID-19 coronavirus disease 2019.